Ex-FDA Commissioner joins Pfizer Ex-FDA Commissioner joins Pfizer Scott Gottlieb will also be a part of the Regulatory and Compliance Committee and the Science and Technology Committee of Pfizer’s Board Newcomer Quell Therapeutics appoints Iain McGill as CEO Newcomer Quell Therapeutics appoints Iain McGill as CEO The company was founded in March 2019, in a partnership between prominent experts from King's College London, University College London, and Hannover Medical School Dr Bartu Ahiska is new Senior VP at Oxford BioDynamics Dr Bartu Ahiska is new Senior VP at Oxford BioDynamics In his new role Ahiska will spearhead the commercialisation of the group’s EpiSwitch technology platform Domain Therapeutics adds Sylvie Ryckebusch to Board Domain Therapeutics adds Sylvie Ryckebusch to Board Ryckebusch joins Domain from Merck Serono Symbiosis Pharmaceutical Services appoints Helen Caddy-Leach Symbiosis Pharmaceutical Services appoints Helen Caddy-Leach Caddy-Leach will take on the role of Business Development Manager to support growing US presence MG America appoints Janice Wortham as Regional Sales Manager MG America appoints Janice Wortham as Regional Sales Manager Wortham will cover the Processing division covering some on the most important pharma stronghold in the US ReViral appoints Alex Sapir as new CEO ReViral appoints Alex Sapir as new CEO Sapir will be based at North Carolina’s Research Triangle Park alongside the company’s new CMO, Seth Hetherington Uhlmann Packaging Systems has new US Regional Sales Manager Uhlmann Packaging Systems has new US Regional Sales Manager Markus Leuprecht will take over leading the Southwestern US and Texas Lyndra Therapeutics has new CEO Lyndra Therapeutics has new CEO Dr Patricia Hurter will begin her new post on 3 September TraceLink appoints four new Board Members TraceLink appoints four new Board Members New appointments include prominent supply chain industry leaders and former industry analysts; Roddy Martin, John Bermudez, Kevin Young and Steve Collins Ulrich Platte is new CFO of eTheRNA immunotherapies Ulrich Platte is new CFO of eTheRNA immunotherapies Platte will start at the mRNA immunotherapy company on 3 June Idifarma announces new Director of Operations Idifarma announces new Director of Operations Daniel Rivero will join the Spanish CDMO from 3P Biopharmaceuticals Immodulon appoints new CSO Immodulon appoints new CSO Effective immediately Thomas Kleen will take on the role within the senior management team Dr William F Feehery is new Certara CEO Dr William F Feehery is new Certara CEO Effective 3 June, Dr William F Feehery will take over the model-informed drug development services company Prudential family leadership goes to third generation Prudential family leadership goes to third generation John Clark, son of departing CEO, Dan Clark, and third generation family member, will assume the CEO position Asceneuron appoints new Board Member Asceneuron appoints new Board Member Dr Eric Yuen will join the company and help initiate later stage clinical development in the tau pathology space